Carcinoma of the nasopharynx. A retrospective analysis of treatment results in 125 patients.
From 1958 to 1982, 125 patients with histologically verified carcinoma of the nasopharynx were treated with external radiotherapy as the sole curative intent. The 5-year actuarial survival rates by stage were as follows: stage I 68%, stage II 64%, stage III 44%, and stage IV 20%. Primary control rate by T-category was 71% in T1, 67% in T2, 52% in T3, and 64% in T4. Regional control rate was 96% in N0, 76% in N1, 61% in N2, and 63% in N3. The T-category was found to be an important prognostic parameter for survival.
Department of Radiotherapy and Oncology, Helsinki University Centeral Hospital, Finland.
M J
MJ
Kajanti
M J
MJ
Mäntylä
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000401:mortality* / Q000532:radiotherapy; D009367:Neoplasm Staging; D012189:Retrospective Studies; D015996:Survival Rate